Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein

Journal of Molecular Biology

Volumn 289, Issue 1, 1999, Pages 123-138

  Geyer, Matthias ^a   Munte, Claudia E ^a   Schorr, Jacqueline ^a   Kellner, Roland ^b   Kalbitzer, Hans Robert ^a,c  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

HIV; Myristoylation; Nef; NMR spectroscopy; Structure determination

Indexed keywords

ARGININE; GLYCINE; NEF PROTEIN; PROTEINASE; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MOLECULAR DYNAMICS; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STOP CODON;

EID: 0033612388     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2740     Document Type: Article

References (65)

1. Adachi A., Gendelmann H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
3. Ames J. B., Tanaka T., Stryer L., Ikura M. Portrait of a myristoyl switch protein. Curr. Opin. Struct. Biol. 6:1996;432-438.
4. Ames J. B., Ishima R., Tanaka T., Gordon J. I., Stryer L., Ikura M. Molecular mechanics of calcium-myritoyl switches. Nature. 389:1997;198-202.
5. Antonny B., Beraud-Dufour S., Chardin P., Chabre M. N-terminal hydrophobic residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids upon GDP to GTP exchange. Biochemistry. 36:1997;4675-4684.
6. Arold S., Franken P., Strub M.-P., Hoh F., Benichou S., Benarous R., Dumas C. The crystal strucutre of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure. 5:1997;1361-1372.
7. Barnham K. J., Monks S. A., Hinds M. G., Azad A. A., Norton R. S. Solution structure of a polypeptide from the N terminus of the HIV protein nef. Biochemistry. 36:1997;5970-5980.
8. Baur A. S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., Peterlin B. M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity. 6:1997;283-291.
9. Bax A., Davis D. G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63:1985a;207-213.
10. Bax A., Davis D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:1985b;355-360.
11. 1H chemical shifts in proteins. J. Biomol. NMR. 9:1997;359-369.
12. Brünger A. T. X-PLOR Manual Version 3.1: A System for X-ray Crystallography and NMR. 1992;Yale University Press, New Haven.
13. Coates K., Cooke S. J., Mann D. A., Harris M. P. G. Protein kinase C-mediated phosphorylation of HIV-1 Nef in human cell lines. J. Biol. Chem. 272:1997;12289-12294.
14. Cullen B. R. The role of Nef in the replication cycle of the human and simian immunodeficiency virus. Virology. 205:1994;1-6.
15. Cullen B. R. HIV-1: is Nef a PAK animal? Curr. Biol. 6:1996;1557-1559.
16. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
17. Fackler O. T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kücherer C., Mueller-Lantzsch N. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247:1997;843-851.
18. Franco M., Chardin P., Charbre M., Paris S. Myristoylation-facilitated binding of the G protein ARF1 to membrane phospholipids is required for its activation by a soluble nucleotide exchange factor. J. Biol. Chem. 271:1996;1573-1578.
19. Freund J. Biophysikalische und proteolytische charkterisierung des HIV-Proteins Nef und Zuordnung des Kernmagnetischen Resonanzey eines Fusions proteins aus Tendamistat und HIV-1-tat. PhD thesis, University of Tübingen. 1994.
20. Freund J., Kellner R., Houthaeve T., Kalbitzer H. R. Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 221:1994a;811-819.
21. Freund J., Kellner R., Konvalinka J., Wolber V., Kräusslich H.-G., Kalbitzer H. R. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223:1994b;589-593.
22. Freund J., Kalbitzer H. R. Physiological buffers for NMR spectroscopy. J. Biomol. NMR. 5:1995;321-322.
23. Garcia J. V., Miller A. D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 350:1991;508-511.
24. Geyer M., Neidig P., Kalbitzer H. R. Automated peak integration in multidimensional NMR spectra by an optimized iterative segmentation procedure. J. Magn. Reson. ser. B. 109:1995;31-38.
25. Greenway A. L., McPhee D. A., Grgacic E., Hewish D., Lucantoni A., Macreadie I., Azad A. A. Nef 27, but not Nef 25 isoform of human immunodeficiency virus-type 1 pNLU.3 down-regulates surface CDU and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology. 198:1994;245-256.
26. Goldberg J. Structural basis for activatioin of ARF GTPase: Mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell. 95:1998;237-248.
27. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene W. C. Dissociation of the CD4 downregulation and viral infectivity enhancement funcions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
28. Grzesiek S., Bax A., Clore G. M., Gronenborn A. M., Hu J.-S., Kaufman J., Palmer I., Stahl S. J., Wingfield P. T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct. Biol. 3:1996a;340-345.
29. Grzesiek S., Stahl S. J., Wingfield P. T., Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surfae by NMR. Biochemistry. 35:1996b;10256-10261.
30. Grzesiek . S., Bax A., Hu J.-S., Kaufman J., Palmer I., Stahl S. J., Tjandra N., Wingfield P. T. Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 6:1997;1248-1263.
31. Harris M. The role of myristoylation in the interactions between human immuno-deficiency virus type 1 Nef and cellular proteins. Biochem. Soc. Trans. 23:1995;557-561.
32. Harris M. From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J. Gen. Virol. 77:1996;2379-2392.
33. IUPAC. Recommendations for the presentation of NMR structures of proteins and nucleic acids. Pure Appl. Chem. 70:1998;117-142.
34. Jeener J., Meier B. H., Bachmann P., Ernst R. R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71:1979;4546-4553.
35. Kaminchik J. ,Margalit R., Yaish S., Drummer H., Amit B., Sarver N., Gorecki M., Panet A. Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent insoluable cellular matrix. AIDS Res. Hum. Retroviruses. 10:1994;1003-1010.
36. Kellner R., Rawer S., Geyer M., Kalbitzer H. R. Myristylated Nef peptide (2-57) from HIV type 1: synthesis and structural studies. Epton R. Innovation and Perspectives in Solid Phase Systhesis. 1996;Mayflower Scientific, Edinburgh.
37. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high viral loads and for development of AIDS. Cell. 65:1991;651-662.
38. Kienzle N., Freund J., Kalbitzer H. R., Mueller-Lantzsch N. Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 214:1993;451-457.
39. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Brief Report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
40. Laskowski R. A., Rullmann J. A. C., MacArthur M. W., Kaptein R., Thornton J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
41. Lee C.-H., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
42. Losonczi J. A., Prestegard J. H. Nuclear magnetic resonance characterization of the myristoylated, N-terminal fragment of ADP-ribosylation factor 1 in a magnetically oriented membrane array. Biochemistry. 37:1998;706-716.
43. Lu X., Wu X., Plemenitas A., Yu H., Sawai E. T., Abo A., Peterlin B. M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6:1996;1677-1684.
44. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113:1983;967-974.
45. McLauglin S., Aderem A. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20:1995;272-276.
46. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Expt. Med. 179:1994;101-113.
47. Neidig K. P., Geyer M., Görler A., Antz C., Saffrich R., Beneicke W., Kalbitzer H. R. AURELIA, a program for computer-aided analysis of multidimensional NMR spectra. J. Biomol. NMR. 6:1995;255-270.
48. Nilges M. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J. Mol. Biol. 245:1995;645-660.
49. Nilges M., Clore G. M., Gronenborn A. M. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Letters. 229:1988;317-324.
50. Niederman T. M. J., Hastings W. R., Ratner L. Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. Virology. 197:1993;420-425.
51. Olejniczak E. T., Eaton H. L. Extrapolation of time-domain data with linear prediction increases resolution and sensitivity. J. Magn. Reson. 87:1990;628-632.
52. Pandori M. W., Fitch N. J. S., Craig H. M., Richman D. D., Spina C. A., Guatelli J. C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:1996;4283-4290.
53. HNα, in a globular protein. J. Mol. Biol. 180:1984;741-751.
54. Rance M., Sørensen O. W., Bodenhausen G., Wagner G., Ernst R. R., Wüthrich K. Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117:1983;479-485.
55. +viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-491.
56. Sawai E. T., Baur A. S., Struble H., Peterlin B. M., Levy J. A., Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl Acad. Sci. USA. 91:1994;1539-1543.
57. Schwartz O., Marechal V., Legall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex class 1 molecules is induced by the HIV-1 Nef protein. Nature Med. 2:1996;338-342.
58. Schorr J., Kellner R., Fakler O., Freund J., Konvalinka J., Kienzle N., Kräusslich H.-G., Mueller-Lantzsch N., Kalbitzer H. R. Specific cleavage sites of Nef-proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J. Virology. 70:1996;9051-9054.
59. States D., Haberkorn R. A., Ruben D. J. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48:1982;286-292.
60. Swingler S., Gallay P., Camaur D., Song J., Abo A., Trono D. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71:1997;4372-4377.
61. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:1995;189-192.
62. Welker R., Kottler H., Kalbitzer H. R., Kräusslich H.-G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 219:1996;228-236.
63. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR. 5:1995;67-81.
64. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;John Wiley & Sons, Inc. New York.
65. Yu G., Felsted R. L. Effect of myristoylation on p27nef subcellular distribution and suppression of HIV-LTR transcription. Virology. 187:1992;46-55.